These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6085073)

  • 1. Assay of prekallikrein as plasminogen proactivator in plasma specimens from reactors to dextran or to contrast media.
    Briseid K; Johansen HT
    Int J Tissue React; 1984; 6(6):529-36. PubMed ID: 6085073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay of kallikrein inhibitors and levels of acetone-activated kallikrein in plasma specimens from reactors to dextran or to contrast media.
    Johansen HT; Hoem NO; Veggeland T; Briseid K
    Int J Tissue React; 1986; 8(3):185-92. PubMed ID: 2430909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran-induced lowering of plasminogen proactivator and functionally active high molecular weight kininogen in the rat.
    Berstad J; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):342-9. PubMed ID: 6180597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of factor XII in acetone-treated human plasma: significance of the functional state of plasma kallikrein for the extent of activation.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):144-50. PubMed ID: 3490738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1984 Jul; 55(1):25-32. PubMed ID: 6431752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
    Briseid G; Briseid K; Toverud EL; Kristoffersen J
    Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of factor XII in human plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Johansen HT
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):344-52. PubMed ID: 6685967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of plasma kallikrein and a kallikrein-like plasminogen activator generated by acetone in rat plasma.
    Johansen HT; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):371-80. PubMed ID: 6554030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma.
    Briseid K; Johansen R; Rustenberg L
    Adv Exp Med Biol; 1979; 120B():101-12. PubMed ID: 517228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by low molecular weight dextran of the blood pressure fall and the lowering of plasminogen proactivator induced by clinical dextran in the rat.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):143-9. PubMed ID: 6189362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contact activation of prekallikrein and plasminogen in plasma].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Pogorelaia NF
    Ukr Biokhim Zh (1978); 1983; 55(3):295-301. PubMed ID: 6553425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.
    Kluft C
    J Lab Clin Med; 1978 Jan; 91(1):83-95. PubMed ID: 618993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of intravenous serotonin and dextran on the levels of factor XII, prekallikrein and plasminogen in rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):314-20. PubMed ID: 6154406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.